A cell-based approach for the biosynthesis/screening of cyclic peptide libraries against bacterial toxins

Chimica Oggi

Volumn 25, Issue 3 SUPPL., 2007, Pages 20-23

  Camarero, Julio A ^a   Kimura, Richard H ^a   Woo, Youn Hi ^a   Cantor, Jason ^a   Steenblock, Erin ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 34547253283     PISSN: 0392839X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. R. P. Hicks, M. G. Hartelt, D. A. Nichols, A. K. Bhattacharjee, J. E. van Hamont, and D. R. Skillman, Curr. Med. Chem. The medicinal chemistry of botulinum, ricin and anthrax toxins Vol. 12, 667-90 (2005).
2. R. A. Greenfield and M. S. Bronze, Drug Discov. Today Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents Vol. 8, 881-8 (2003).
3. G. J. Rainey and J. A. Young, Nat. Rev. Microbiol. Antitoxins: novel strategies to target agents of bioterrorism Vol. 2, 721-6 (2004).
4. L. O. Haustedt, C. Mang, K. Siems, and H. Schiewe, Curr. Opin. Drug Discov. Devel. Rational approaches to natural-product-based drug design Vol. 9, 445-62 (2006).
5. B. Waszkowycz, Curr. Opin. Drug Discov. Devel. Structure-based approaches to drug design and virtual screening Vol. 5, 407-13 (2002).
6. K. S. Lam, M. Lebl, and V. Krchnak, Chem. Rev. The "One-Bead-One- Compound" Combinatorial Library Method Vol. 97, (1997).
7. T. Clackson, H. R. Hoogenboom, A. D. Griffiths, and G. Winter, Nature Making antibody fragments using phage display libraries Vol. 352, 624-8 (1991).
8. I. Kaganman, Nat. Methods FRETting for a more detailed interactome Vol. 4, 112-3 (2007).
9. B. N. Giepmans, S. R. Adams, M. H. Ellisman, and R. Y. Tsien, Science The fluorescent toolbox for assessing protein location and function Vol. 312, 217-24 (2006).
10. X. You, A. W. Nguyen, A. Jabaiah, M. A. Sheff, K. S. Thorn, and P. S. Daugherty, Proc. Natl. Acad. Sci. USA Intracellular protein interaction mapping with FRET hybrids Vol. 103, 18458-63 (2006).
11. J. A. Camarero, R. Kimura, and A. T. Tran, J. Pept. Sci. A Cell-based Approach for Biosynthesis/Screening of Cyclic Peptide Libraries against Bacterial Toxins Vol. 12, 89 (2006).
12. S. H. Leppla, Proc. Natl. Acad. Sci. USA Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells Vol. 79, 3162-6 (1982).
13. K. R. Klimpel, N. Arora, and S. H. Leppla, Mol. Microbiol. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity Vol. 13, 1093-100 (1994).
14. C. Montecucco, F. Tonello, and G. Zanotti, Trends Biochem. Sci. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease Vol. 29, 282-5 (2004).
15. K. A. Bradley, J. Mogridge, M. Mourez, R. J. Collier, and J. A. Young, Nature Identification of the cellular receptor for anthrax toxin Vol. 414, 225-9 (2001).
16. H. M. Scobie, G. J. Rainey, K. A. Bradley, and J. A. Young, Proc. Natl. Acad. Sci. USA Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor Vol. 100, 5170-4 (2003).
17. E. Santelli, L. A. Bankston, S. H. Leppla, and R. C. Liddington, Nature Crystal structure of a complex between anthrax toxin ana its host cell receptor Vol. 430, 905-8 (2004).
18. V. M. Gordon, K. R. Klimpel, N. Arora, M. A. Henderson, and S. H. Leppla, infect. Immun. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases Vol. 63, 82-7 (1995).
19. J. C. Milne, D. Furlong, P. C. Hanna, J. S. Wall, and R. J. Collier, J. Biol. Chem. Anthrax protective antigen forms oligomers during intoxication of mammalian cells Vol. 269, 20607-12 (1994).
20. J. M. Park, F. R. Greten, Z. W. Li, and M. Karin, Science Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition Vol. 297, 2048-51 (2002).
21. J. E. Kirby, Infect. Immun. Anthrax lethal toxin induces human endothelial cell apoptosis Vol. 72, 430-9 (2004).
22. A. Agrawal, J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran, Nature Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin Vol. 424, 329-34 (2003).
23. R. H. Kimura, A. T. Tran, and J. A. Camarero, Angew. Chem. Int. Ed. Biosynthesis of the cyclotide kalata Bl by using protein splicing Vol. 45, 973-6 (2006).
24. D. J. Craik, N. L. Daly, T. Bond, and C. Waine, J. Mol. Biol. Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif Vol. 294, 1327-36 (1999).
25. K. J. Rosengren, N. L. Daly, M. R. Plan, C. Waine, and D. J. Craik, J. Biol. Chem. Twists, knots, and rings in proteins. Structural definition of the cyclotide framework Vol. 278, 8606-16 (2003).
26. M. L. Colgrave and D. J. Craik, Biochemistry Thermal, chemical, and enzymatic stability of the cyclotide kalata Bl : the importance of the cyclic cystine knot Vol. 43, 5965-75 (2004).
27. U. Goransson, E. Svangard, P. Claeson, and L. Bohlin, Curr. Protein Pept. Sci. Novel strategies for isolation and characterization of cyclotides: the discovery of bioactive macrocyclic plant polypeptides in the Violaceae Vol. 5, 317-29 (2004).
28. D. J. Craik, N. L. Daly, J. Mulvenna, M. R. Plan, and M. Trabi, Curr. Protein Pept. Sci. Discovery, structure and biological activities of the cyclotides Vol. 5, 297-315 (2004).
29. D. J. Craik, M. Cemazar, C. K. Wang, and N. L. Daly, Biopolymers The cyclotide family of circular miniproteins: nature's combinatorial peptide template Vol. 84, 250-66 (2006).
30. D. J. Craik, M. Cemazar, and N. L. Daly, Curr. Opin. Drug Discov. Devel. The cyclotides and related macrocyclic peptides as scaffolds in drug design Vol. 9, 251-60 (2006).
31. P. E. Dawson and S. B. Kent, Annu. Rev. Biochem. Synthesis of native proteins by chemical ligation Vol. 69, 923-60 (2000).
32. J. A. Camarero, J. Pavel, and T. W. Muir, Angew. Chem. Int. Ed. Chemical Synthesis of a Circular Protein Domain: Evidence for Folding-Assisted Cyclization Vol. 37, 347-349 (1998).
33. J. A. Camarero and T. W. Muir, J. Am. Chem. Soc. Biosynthesis of a Head-to-Tail Cyclized Protein with Improved Biological Activity Vol. 121, 5597-5598 (1999).
34. T. W. Muir, Annu. Rev. Brochem. Semisynthesis of proteins by expressed protein ligation Vol. 72, 249-289 (2003).
35. J. A. Camarero, D. Fushman, D. Cowburn, and T W. Muir, Bioorg, Med. Chem. Peptide chemical ligation Inside living cells: in vivo generation of a circular protein domain Vol. 9, 2479-84, (2001).
36. M. L. Korsinczky, H. J. Schirra, and D. J. Craik, Curr. Protein Pept. Sci. Sunflower trypsin inhibitor-1 Vol. 5, 351-64 (2004).
37. R. F. Qi, Z. W. Song, and C. W. Chi, Acta Biochim. Biophys. Sin (Shanghai) Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application Vol. 37, 283-92 (2005).
38. A. W. Nguyen and P S. Dougherty, Nat. Biotechnol. Evolutionary optimization of fluorescent proteins for intracellular FRET Vol. 23, 355-60 (2005).
39. B. E. Turk, T. Y. Wong, R. Schwarzenbacher, E. T. Jarrell, S. H. Leppla, R. J. Collier, R. C. Liddington, and L. C. Cantley, Nat. Struct. Mol. Biol. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor Vol. 11, 60-6 (2004).
40. T. H. Evers, E. M. van Dongen, A. C. Faesen, E. W. Meijer, and M. Merkx, Biochemistry Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers Vol. 45, 13183-92 (2006).
41. T Som and J. Tomizawa, Mol. Gen. Genet. Origin of replication of Escherichia coli plasmid RSF 1030 Vol. 187, 375-83 (1982).
42. D. S. Burz, K. Dutta, D. Cowburn, and A. Shekhtman, Nat. Methods Mapping structural interactions using in-cell NMR spectroscopy (STINTNMR)Vol. 3, 91-3 (2006).
43. R. Kimura and J. A. Camarero, Protein Pept. Lett. Expressed protein ligation: a new tool for the biosynthesis of cyclic polypeptides Vol. 12, 789-94 (2005).
44. D. J. Craik, S. Simonsen, and N. L. Daly, Curr. Opin. Drug Discov. Devel. The cyclotides: novel macrocyclic peptides as scaffolds in drug design Vol. 5, 251-260 (2002).
45. J. A. Camarero, R. H. Kimura, Y.-H. Woo, A. Shekhtman and J. Cantor, CriemBioChem Biosynthesis of a Fully Functional Cyclotide inside Living Bacterial Cells, DOI 10.1002/cbic.200700183